✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Jubilant Pharmova Ltd

Common Name
Jubilant Pharmova
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5,547
Ticker
JUBLPHARMA
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Jubilant Pharmova Ltd. is a prestigious pharmaceutical and life sciences company operating primarily in the healthcare domain. Its core mission is to innovate in the areas of pharmaceutical formulatio...

Jubilant Pharmova's GHG Emissions Data Preview

In 2025, Jubilant Pharmova completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Jubilant Pharmova has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202520242023
2022 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Jubilant Pharmova’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2024, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=JUBLPHARMA&reporting_period=2024"

Verified Sources Behind Jubilant Pharmova’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jubilant Pharmova’s data sources below and access millions more through our Disclosure Search.

a. Jubilant Pharmova's Annual Report 2025

Insights into Jubilant Pharmova's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Jubilant Pharmova amounted to 74,303 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Jubilant Pharmova decreased by 3.22%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Jubilant Pharmova's Scope 1 Emissions Over Time

2024202503 k6 k9 k12 ktCO2e+17%
  • Total Scope 1
  • Year-over-Year Change

What are Jubilant Pharmova's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Jubilant Pharmova were 10,084 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2024), Jubilant Pharmova's Scope 1 emissions increased by 16.98%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Jubilant Pharmova's Scope 2 emissions?

In 2025, Jubilant Pharmova reported Scope 2 greenhouse gas (GHG) emissions of 64,219 tCO₂e without specifying the calculation method.a

Has Jubilant Pharmova reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Jubilant Pharmova's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Jubilant Pharmova's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Jubilant Pharmova use for Scope 2 reporting?

In 2025, Jubilant Pharmova reported its Scope 2 emissions using an unspecified methodology.a

Jubilant Pharmova's Scope 2 Emissions Over Time

20242025020 k40 k60 k80 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Jubilant Pharmova's Value Chain Emissions

In 2025, Jubilant Pharmova reported 527,407 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Jubilant Pharmova includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Jubilant Pharmova's Scope 3 Emissions Over Time

202420250200 k400 k600 k800 ktCO2e-28%
  • Total Scope 3
  • Year-over-Year Change

What are Jubilant Pharmova's Scope 3 emissions?

In 2025, Jubilant Pharmova reported total Scope 3 emissions of 527,407 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2024), Jubilant Pharmova's Scope 3 emissions decreased by 28.46%, highlighting the company's efforts to lower indirect emissions from its value chain.a

Insights into Jubilant Pharmova’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Jubilant Pharmova reported Scope 1 greenhouse gas (GHG) emissions of 10,084 tCO₂e and total revenues of USD 842 millions. This translates into an emissions intensity of 11.98 tCO₂e per millions USD.a

Jubilant Pharmova's Scope 1 Emissions Intensity Compared to Peers

1005005,00050,000500,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OEJMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2025Scope 1: 56,459 tCO2eRevenue: $M 2,642Scope 1 Intensity: 21.37 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MWockhardtYear: 2025Scope 1: 11,404 tCO2eRevenue: $M 341Scope 1 Intensity: 33.43 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MEEEris LifesciencesYear: 2025Scope 1: 1,083 tCO2eRevenue: $M 337Scope 1 Intensity: 3.21 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$M

How does Jubilant Pharmova's GHG emissions intensity compare to its peers?

In 2025, Jubilant Pharmova reported a Scope 1 emissions intensity of 11.98 tCO₂e per millions USD. Compared to the peer group median of 24.05, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Jubilant Pharmova rank on GHG emissions intensity within its industry?

In 2025, Jubilant Pharmova ranked 6 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Jubilant Pharmova is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Jubilant Pharmova's Total Carbon Footprint

In 2025, Jubilant Pharmova reported a total carbon footprint of 601,710 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 26.08% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to Jubilant Pharmova's total carbon footprint was Scope 3 emissions, accounting for 87.65% of the company's total carbon footprint, followed by Scope 2 emissions at 10.67%.a

Want Full Access to Jubilant Pharmova's GHG Emissions Dataset?
Start 30-Day Free Trial